Article content material
Mr. Rabinovitch is among the international hashish senior executives to take part
NEW YORK, TORONTO, and HERZLIYA, Israel, Might 15, 2023 (GLOBE NEWSWIRE) — InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)(“InterCure”) immediately introduced that Alexander Rabinovitch, CEO of InterCure, will take part within the Cowen 3rd Annual European Hashish Convention, happening Might 16th, 2023 in Berlin, Germany.
Article content material
Mr. Rabinovitch will participate within the European Frontier Markets & Israel panel on Might 16th, 2023 at 10:35 AM CEST, and can be out there for 1 on 1 classes by appointment solely.
Article content material
About InterCure (dba Canndoc)
InterCure (dba Canndoc) (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) is the main, worthwhile, and quickest rising hashish firm outdoors of North America. Canndoc, an entirely owned subsidiary of InterCure, is Israel’s largest licensed hashish producer and one of many first to supply Good Manufacturing Practices (GMP) licensed and pharmaceutical-grade medical hashish merchandise. InterCure leverages its market main distribution community, finest in school worldwide partnerships and a high-margin vertically built-in “seed-to-sale” mannequin to steer the quickest rising hashish international market outdoors of North America.
For extra data, go to: http://www.intercure.co.
Contact:
InterCure Ltd.
Amos Cohen, Chief Monetary Officer
amos@intercure.co
Source link